Back to top
more

Tilray Brands (TLRY)

(Delayed Data from NSDQ)

$1.80 USD

1.80
13,168,434

-0.01 (-0.28%)

Updated Jun 3, 2024 04:00 PM ET

After-Market: $1.80 +0.01 (0.28%) 4:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (62 out of 250)

Industry: Consumer Products - Staples

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for TLRY

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

Tilray Brands, Inc. [TLRY]

Reports for Purchase

Showing records 201 - 219 ( 219 total )

Company: Tilray Brands, Inc.

Industry: Medical - Drugs

Record: 201

02/20/2019

Company Report

Pages: 5

TLRY to Acquire Manitoba Harvest Leader in Hemp Food

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 10.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Medical - Drugs

Record: 202

01/14/2019

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Medical - Drugs

Record: 203

01/14/2019

Industry Report

Pages: 10

Canadian LPs Update

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 25.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Medical - Drugs

Record: 204

01/11/2019

Daily Note

Pages: 5

Lock-Up - Privateer Shares

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 10.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Medical - Drugs

Record: 205

12/21/2018

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Medical - Drugs

Record: 206

12/21/2018

Industry Report

Pages: 23

Cannabis Market Highlights

Provider: Echelon Welath Partners

Price: 75.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Medical - Drugs

Record: 207

12/20/2018

Company Report

Pages: 8

Executing on Global Distribution - Pharmaceutical and Beverage Partners

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 25.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Medical - Drugs

Record: 208

12/14/2018

Industry Report

Pages: 23

Cannabis Market Highlights

Provider: Echelon Welath Partners

Price: 75.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Medical - Drugs

Record: 209

11/14/2018

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Medical - Drugs

Record: 210

11/14/2018

Company Report

Pages: 7

3Q18 Recap - In line results, 4Q Rec Demand Strong, Limited Store Supply

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 25.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Medical - Drugs

Record: 211

10/02/2018

Industry Report

Pages: 63

Consumer - Canada Leading the Global Cannabis Industry - The Playbook

Provider: Roth Capital Partners, Inc.

Price: 150.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Medical - Drugs

Record: 212

10/02/2018

Company Report

Pages: 9

Transfer of Coverage

Provider: Roth Capital Partners, Inc.

Price: 25.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Medical - Drugs

Record: 213

09/18/2018

Daily Note

Pages: 2

MORNING NOTE

Provider: M Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Unclassified

Record: 214

08/30/2018

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Unclassified

Record: 215

08/29/2018

Company Report

Pages: 9

2Q Results - Strong Results; Reducing to Neutral on Valuation

Provider: Roth Capital Partners, Inc.

Analyst: FINNIE C

Price: 25.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Unclassified

Record: 216

08/15/2018

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Unclassified

Record: 217

08/14/2018

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Unclassified

Record: 218

08/14/2018

Daily Note

Pages: 5

Ontario Government Delays Launch of Recreational Cannabis Sales

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Tilray Brands, Inc.

Industry: Unclassified

Record: 219

08/13/2018

Company Report

Pages: 27

A Global Cannabis Leader - Initiating with Buy; $35 12-month Price Target

Provider: Roth Capital Partners, Inc.

Price: 75.00

Research Provided by a Third Party